.png)
KUALA LUMPUR – From now on, the reporting and monitoring of asymptomatic Covid-19 patients will be done totally through the MySejahtera platform.
Health Director-General Tan Sri Dr Noor Hisham Abdullah said this would involve home assessment tool (HAT) self-reporting, notifications to complete the HAT, notifications to report warning signs, as well as notifications for individuals eligible for Paxlovid antiviral drug treatment.
He said this is following the termination of automated voice recordings for those yet to respond to HAT questions in the MySejahtera app, as well as the CPRC hotline and national CAC helpline that operated from 2020 until 2022.
“The Health Ministry would like to remind all individuals, especially those confirmed positive, to activate the MySejahtera app’s notification function on their smartphones to ensure that the self-monitoring mechanism is functioning well,” he said in a statement today.
Dr Noor Hisham said virtual monitoring of Covid-19 patients will be continued by the task force at Covid-19 assessment centres and health clinic fever centres, while the state-level crisis preparedness and emergency response centres will continue to monitor the Covid-19 situation in their respective states.
He said home surveillance and observation orders and release orders would be given as usual through MySejahtera.
Meanwhile, Dr Noor Hisham said the number of new daily Covid-19 cases in the 52nd epidemiological week (ME52/2022) from December 25 to December 31 dropped by 36.1% with 3,767 cases in contrast with 5,894 cases in ME51/2022.
He said the number of local cases showed a 36.5% drop from 5,880 cases to 3,735 cases, while the number of imported cases rose from 14 cases to 32 cases.
Dr Noor Hisham said the number of deaths also dropped by 29% or 22 cases that week compared with 31 cases previously.
“The average daily active cases for ME52/2022 decreased by 14.7% (14,580 cases to 12,433 cases),” he said, adding that the average infectivity rate during the week was 0.79. – Bernama, January 2, 2023